货号:A1455244
同义名:
培氟沙星
/ Pefloxacinium mesylate dihydrate; Pefloxacin (mesylate hydrate)
Pefloxacin mesylate dihydrate是一种第三代氟喹诺酮类抗生素,通过抑制 DNA 旋转酶(DNA gyrase)阻止细菌 DNA 复制,用于治疗各种细菌感染。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Topo I ↓ ↑ | Topo II ↓ ↑ | Topo IV ↓ ↑ | Topoisomerase ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ellagic acid | ✔ | 98% | |||||||||||||||||
| β-Lapachone | ✔ | 99%+ | |||||||||||||||||
| (s)-10-hydroxycamptothecin | ✔ | 98+% | |||||||||||||||||
| Camptothecin |
++
Topo I, IC50: 0.68 μM |
98% | |||||||||||||||||
| Betulinic acid |
++
Eukaryotic topoisomerase I, IC50: 5 μM |
98% | |||||||||||||||||
| Topotecan |
++++
Topo I (DU-145 Luc cells), IC50: 2 nM Topo I (MCF-7 Luc cells), IC50: 13 nM |
98% | |||||||||||||||||
| Irinotecan HCl Trihydrate | ✔ | 98% | |||||||||||||||||
| SN-38 | ✔ | 98% | |||||||||||||||||
| Levofloxacin hydrate | ✔ | 98% | |||||||||||||||||
| Dexrazoxane | ✔ | 99%+ | |||||||||||||||||
| Ofloxacin | ✔ | 98+% | |||||||||||||||||
| Enoxacin | ✔ | 99%+ | |||||||||||||||||
| Flumequine |
+
Topo II, IC50: 15 μM |
98% | |||||||||||||||||
| Levofloxacin | ✔ | 97% | |||||||||||||||||
| Etoposide | ✔ | 98% | |||||||||||||||||
| Pefloxacin mesylate dihydrate | ✔ | 99.5% | |||||||||||||||||
| Marbofloxacin | ✔ | 98+% | |||||||||||||||||
| Voreloxin HCl | ✔ | 98% | |||||||||||||||||
| Mitoxantrone 2HCl | ✔ | PKC | 98% | ||||||||||||||||
| Nalidixic acid | ✔ | 98% | |||||||||||||||||
| Doxorubicin | ✔ | 97% | |||||||||||||||||
| Novobiocin sodium | ✔ | 95% | |||||||||||||||||
| Amonafide | ✔ | 99%+ | |||||||||||||||||
| Pirarubicin | ✔ | 98%+ | |||||||||||||||||
| Idarubicin HCl |
+++
Topo II (MCF-7 cells), IC50: 3.3 ng/mL |
99%+ | |||||||||||||||||
| Genistein | ✔ | EGFR | 98% | ||||||||||||||||
| Teniposide | ✔ | 98% | |||||||||||||||||
| Moxifloxacin | ✔ | 98% | |||||||||||||||||
| Ciprofloxacin | ✔ | 98% | |||||||||||||||||
| Clinafloxacin | ✔ | 99% | |||||||||||||||||
| Gatifloxacin | ✔ | 98% | |||||||||||||||||
| Daunorubicin HCl |
+++
DNA synthesis, Ki: 20 nM |
98% | |||||||||||||||||
| Epirubicin HCl | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| Concentration | Treated Time | Description | References | |
| Salmonella enterica | 5 μg | 16-20 hours | To evaluate the ability of pefloxacin disk diffusion method to detect fluoroquinolone-resistant Salmonella enterica. Results showed that the 5 μg pefloxacin disk correctly identified all resistant isolates. | J Clin Microbiol. 2015 Nov;53(11):3411-7 |
| Xenopus oocytes expressing human α4β2 nAChRs | 100 µM | 30 s preapplication + 5 s coapplication | To investigate the inhibitory effects of Pefloxacin on two stoichiometries of α4β2 nAChRs. Results showed that Pefloxacin significantly inhibited (α4)2(β2)3 nAChRs (inhibition of 73.3 ± 1.9%) but had no significant effect on (α4)3(β2)2 nAChRs. | ACS Chem Neurosci. 2022 Jun 15;13(12):1805-1817 |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley rats | Male Sprague-Dawley rats | Intravenous injection | 10 mg/kg | Single dose | To investigate the pharmacokinetics of pefloxacin and its interaction with cyclosporin A in rat blood, brain, and bile. Results showed that pefloxacin could penetrate the blood-brain barrier, and the concentration in bile was higher than in blood, suggesting active biliary excretion of pefloxacin. Cyclosporin A had no significant impact on the pharmacokinetics of pefloxacin in rat blood and brain. | Br J Pharmacol. 2001 Mar;132(6):1310-6 |
| Mice | Normal mice | Oral | 400 mg/kg | Single dose | Measure proteoglycan synthesis, observed early inhibition followed by a repair-like response | Antimicrob Agents Chemother. 2000 Apr;44(4):867-72 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.15mL 0.43mL 0.21mL |
10.74mL 2.15mL 1.07mL |
21.48mL 4.30mL 2.15mL |
|
| CAS号 | 149676-40-4 |
| 分子式 | C18H28FN3O8S |
| 分子量 | 465.49 |
| SMILES Code | O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCN(C)CC3)=C2)C1=O)O.CS(=O)(O)=O.[H]O[H].[H]O[H] |
| MDL No. | MFCD01685696 |
| 别名 | 培氟沙星 ;Pefloxacinium mesylate dihydrate; Pefloxacin (mesylate hydrate); Peflacin; Pefloxacin (mesylate dihydrate); UNII-CX28QC6FU0; Peflacine |
| 运输 | 蓝冰 |
| InChI Key | LEULAXMUNMRLPW-UHFFFAOYSA-N |
| Pubchem ID | 6917670 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, room temperature |
沪公网安备 31011702889066号
沪ICP备2024050318号-1